1. Home
  2. KURA vs LIND Comparison

KURA vs LIND Comparison

Compare KURA & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • LIND
  • Stock Information
  • Founded
  • KURA 2014
  • LIND 1979
  • Country
  • KURA United States
  • LIND United States
  • Employees
  • KURA N/A
  • LIND N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • LIND Transportation Services
  • Sector
  • KURA Health Care
  • LIND Consumer Discretionary
  • Exchange
  • KURA Nasdaq
  • LIND Nasdaq
  • Market Cap
  • KURA 561.9M
  • LIND 618.2M
  • IPO Year
  • KURA N/A
  • LIND N/A
  • Fundamental
  • Price
  • KURA $6.47
  • LIND $12.13
  • Analyst Decision
  • KURA Strong Buy
  • LIND Strong Buy
  • Analyst Count
  • KURA 12
  • LIND 4
  • Target Price
  • KURA $24.50
  • LIND $15.75
  • AVG Volume (30 Days)
  • KURA 1.4M
  • LIND 302.4K
  • Earning Date
  • KURA 08-07-2025
  • LIND 08-04-2025
  • Dividend Yield
  • KURA N/A
  • LIND N/A
  • EPS Growth
  • KURA N/A
  • LIND N/A
  • EPS
  • KURA N/A
  • LIND N/A
  • Revenue
  • KURA $67,991,000.00
  • LIND $670,834,000.00
  • Revenue This Year
  • KURA $125.04
  • LIND $16.97
  • Revenue Next Year
  • KURA $83.75
  • LIND $9.34
  • P/E Ratio
  • KURA N/A
  • LIND N/A
  • Revenue Growth
  • KURA N/A
  • LIND 15.71
  • 52 Week Low
  • KURA $5.41
  • LIND $6.76
  • 52 Week High
  • KURA $21.60
  • LIND $14.34
  • Technical
  • Relative Strength Index (RSI)
  • KURA 55.28
  • LIND 49.72
  • Support Level
  • KURA $6.26
  • LIND $12.19
  • Resistance Level
  • KURA $6.74
  • LIND $13.06
  • Average True Range (ATR)
  • KURA 0.31
  • LIND 0.48
  • MACD
  • KURA 0.05
  • LIND -0.11
  • Stochastic Oscillator
  • KURA 75.25
  • LIND 4.37

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

About LIND Lindblad Expeditions Holdings Inc.

Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.

Share on Social Networks: